Peking University First Hospital

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

205

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

21 drugs in development

Approved2

Phase 35

Phase 21

Phase 15

Preclinical12

By Therapeutic Area

top 6

Oncology

624%

Cardiovascular

28%

Gastroenterology

28%

Infectious Disease

14%

Nephrology

14%

Immunology

14%

R&D Momentum

84/100

Pipeline Velocity

61/100

Trial Completion Rate

87/100

Pipeline Concentration

21/100

Pipeline Freshness

63/100

Strategic Signals

↗Active in Infectious Disease but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Sep 17, 2026

Recruiting

A Clinical Study on Minimal Residual Disease in Patients With Systemic Light Chain Amyloidosis

Sep 17, 2026

Recruiting

A Prospective Cohort Study of Patients With Plasma Cell Disorders (PCDs) in PKUFH

Sep 17, 2026

Active, not recruiting

Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors and Discovery of Potential Drug Targets

Earlier

Sep 5, 2026TrialMini-dose Dexmedetomidine-Esketamine Supplemented Analgesia for Postoperative Sleep Promotion in Patients at High-risk of Obstructive Sleep Apnea: A Randomized Trial

Sep 3, 2026TrialClinical Study of Glypican-3 (GPC3)-Targeted Novel Probe 18F-X12 for the Diagnosis of Hepatocellular Carcinoma (HCC)

Aug 21, 2026TrialEvaluation of Chemotherapy With Adjuvant Docetaxel After Radiotherapy for Localized High Malignant Prostate Cancer: A Prospective Muti-center Non-Randomized Controlled Trial

Aug 20, 2026TrialClinical Evaluation of a 68Ga-Labeled B7-H3 Nanobody for ImmunoPET Imaging in Patients With Osteosarcoma

Aug 18, 2026TrialEfficacy and Safety Evaluation of Lishitonglin Formula in Improving Preoperative Non-Severe Urinary Tract Infections and Lower Urinary Tract Symptoms in Patients With Urethral Stricture

3 more events

Aug 15, 2026TrialPerioperative Use of Dexmedetomidine-esketamine Combination on Depression and Anxiety in Patients Undergoing Laparoscopic Ureteral Reconstruction: a Randomized Controlled Trial

Aug 12, 2026TrialEffects of Oliceridine Versus Sufentanil Analgesia on Incidence of Postoperative Respiratory Depression in Patients at High-Risk of Obstructive Sleep Apnea: A Prospective Cohort Study

Aug 12, 2026TrialFascia Iliaca Block Using Liposomal Bupivacaine for Analgesia After Hip Surgery: a Randomized Trial

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Therapeutic Area

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Cardiovascular(2 drugs)

—

Cardiovascular(2 drugs)

Gastroenterology(2 drugs)

—

Gastroenterology(2 drugs)

Hematology(1 drug)

—

Hematology(1 drug)

Immunology(1 drug)

—

Immunology(1 drug)

Infectious Disease(1 drug)

—

Infectious Disease(1 drug)

Metabolic & Endocrine(1 drug)

—

Metabolic & Endocrine(1 drug)

Nephrology(1 drug)

—

Nephrology(1 drug)

Neurology(1 drug)

—

Neurology(1 drug)

Oncology(6 drugs)

—

Oncology(6 drugs)

Unknown / Other(9 drugs)

—

Unknown / Other(9 drugs)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)